Filing Flows › Chemed (CHE) › Q1 2025
Chemed (CHE) Q1 2025 earnings results (first quarter 2025)
10-Q filed Apr 28, 2025
Chemed (CHE) reported revenue of $647M for the first quarter 2025 (Q1 2025), +10% from a year earlier and +1% from the quarter before. Operating margin was 14.6%, net earnings $71.8M (11.1% of revenue).
Chemed, Q1 2025: revenue $647M (+10% year over year), operating margin 14.6%, net earnings $71.8M, operating cash flow $32.7M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $647M | +1% | +10% |
| Operating profit | $94.8M | -17% | +31% |
| Net earnings | $71.8M | -21% | +10% |
| Operating cash flow | $32.7M | -80% | -61% |
| Free cash flow | $19.0M | -88% | -71% |
What changed
Revenue was $646.9M in Q1 2025, up 10% year over year and up 1% from the previous quarter. VITAS was the largest line at 63% of revenue. VITAS added $53.4M year over year (up 15%), 93% of the total change.
Operating profit was $94.8M, a 14.6% margin (up 2.4 points year over year). Of the extra revenue versus a year earlier, 39% reached operating profit, above the 12% margin then. Total costs grew 7% against revenue growth of 10%. The fastest-growing cost line was Cost of revenue (+12%). Net earnings were $71.8M, up 10% year over year. The effective tax rate was 25.0%.
Operating cash flow was $32.7M (down 61% year over year), 46% of net earnings. Non-cash charges added back $16.0M of depreciation and amortization. Working capital and other items used $55.0M. Capital expenditures of $13.8M left free cash flow of $19.0M.
Questions
What was Chemed's revenue in the first quarter 2025?
Chemed (CHE) reported revenue of $647M for the first quarter 2025 (Q1 2025), +10% from a year earlier and +1% from the quarter before.
Was Chemed profitable in the first quarter 2025?
Operating profit was $94.8M (14.6% of revenue) and net earnings $71.8M.
Source: Chemed 10-Q on SEC EDGAR.